Literature DB >> 6271784

Mapping the substrate binding site of human C1r and C1s with peptide thioesters. Development of new sensitive substrates.

B J McRae, T Y Lin, J C Powers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6271784

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  10 in total

1.  alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.

Authors:  Thomas Sulikowski; Bryan A Bauer; Philip A Patston
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

2.  Mutants of complement component C3 cleaved by the C4-specific C1-s protease.

Authors:  P Mathias; C J Carrillo; N E Zepf; N R Cooper; R T Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 3.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

4.  A novel human complement-related protein, C1r-like protease (C1r-LP), specifically cleaves pro-C1s.

Authors:  Christina Ligoudistianou; Yuanyuan Xu; Gerard Garnier; Antonella Circolo; John E Volanakis
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

5.  New class of sensitive and selective fluorogenic substrates for serine proteinases. Amino acid and dipeptide derivatives of rhodamine.

Authors:  S P Leytus; W L Patterson; W F Mangel
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

6.  Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.

Authors:  Lakshmi C Wijeyewickrema; Emilie Lameignere; Lilian Hor; Renee C Duncan; Toshikazu Shiba; Richard J Travers; Piyushkumar R Kapopara; Victor Lei; Stephanie A Smith; Hugh Kim; James H Morrissey; Robert N Pike; Edward M Conway
Journal:  Blood       Date:  2016-06-23       Impact factor: 22.113

7.  Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.

Authors:  J C Jennette; R R Tidwell; J D Geratz; D H Bing; R J Falk
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

Review 8.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

9.  Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.

Authors:  R Zahedi; J J Bissler; A E Davis; C Andreadis; J J Wisnieski
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids.

Authors:  Chen-Fu Lo; Tai-Yu Chiu; Yu-Tzu Liu; Li-Rung Huang; Teng-Kuang Yeh; Kuan-Hsun Huang; Kuan-Liang Liu; Chia-Yu Hsu; Ming-Yu Fang; Yu-Chen Huang; Tsu-An Hsu; Chiung-Tong Chen; Lun Kelvin Tsou
Journal:  Pharmaceutics       Date:  2022-06-21       Impact factor: 6.525
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.